|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's range||55.28 - 55.94|
|52-week range||49.83 - 89.70|
|Beta (5Y monthly)||0.59|
|PE ratio (TTM)||27.68|
|Earnings date||15 Feb 2023 - 20 Feb 2023|
|Forward dividend & yield||1.16 (2.10%)|
|Ex-dividend date||01 Dec 2022|
|1y target est||63.73|
DEERFIELD, Ill., November 16, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
DEERFIELD, Ill., November 15, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 3, 2023, to shareholders of record as of December 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.
DEERFIELD, Ill., November 07, 2022--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida. Key data highlighted include: